North Chicago Business
-
Abbott faces probe over marketing of DepakoteNov 05, 2009 10:00 pm - Abbott Laboratories said it is being investigated by the U.S. Justice Department over "sales and marketing activities" for Depakote, its third top-selling drug. The inve...
-
Judge upholds Abbott's $1.67 billion patent suit loss to J&JNov 04, 2009 10:00 pm - Abbott Laboratories failed to convince a federal judge to throw out a record $1.67 billion verdict won by Johnson & Johnson's Centocor unit in a suit over an arthritis d...
-
Study: Abbott's Niaspan reduces arteries' plaque buildupNov 01, 2009 10:00 pm - Combining Abbott Laboratories' cholesterol pill Niaspan with an older medicine, called a statin, reduced plaque buildup more than the statin alone, a study found. Patien...
-
Analysts question Abbott's Solvay acquisitionOct 11, 2009 11:00 pm - WASHINGTON -- Drug and medical-device company Abbott Laboratories is scheduled to report earnings for the third quarter on Wednesday. The following is a summary of key ...
-
Abbott buys Solvay pharma operations for $6.6 bilSep 27, 2009 11:00 pm - NEW YORK -- Abbott Laboratories on Monday said it would pay $6.6 billion for the pharmaceutical business of Belgian chemicals maker Solvay in a move to further expand in...
-
Abbott to buy maker of heart valve repair devices for $400 millionSep 10, 2009 11:00 pm - Abbott Laboratories said it agreed to buy Evalve Inc., the maker of heart valve repair devices, for as much as $410 million. Libertyville Township-based Abbott will pay ...
-
Abbott Labs sued by doc over heart device patentAug 24, 2009 11:00 pm - Abbott Laboratories, which recently lost the largest verdict in the history of patent litigation, was sued by a New Jersey doctor who claims the company infringed his pa...
-
Abbott expanding study of its popular Xience stentAug 12, 2009 11:00 pm - TRENTON, N.J. -- Abbott Laboratories Inc. is expanding a study of its top-selling heart stent by more than 2,000 patients, who may also be put in a second, landmark sten...
-
Abbott claims J&J's psoriasis drug infringes patentsAug 10, 2009 11:00 pm - Abbott Laboratories, which is fighting to void a $1.67 billion patent-infringement verdict won by Johnson & Johnson's Centocor unit, filed a lawsuit claiming a J&J drug ...
-
J&J: Abbott owes $2.1 billion in Humira royaltiesJun 22, 2009 11:00 pm - Johnson & Johnson's Centocor told a U.S. jury today it was entitled to a $2.1 billion slice of the revenue Abbott Laboratories gets from selling the arthritis drug Humir...